Beta Blockade and Clinical Outcomes in Aneurysmal Subarachnoid Hemorrhage



Melody M. Chang1, Ronak N. Raval1, *, Jessie J. Southerland2, Dare A. Adewumi3, Khaled A. Bahjri4, Rajeev K. Samuel1, Rafeek O. Woods1, Olaide O. Ajayi1, Bryan S. Lee5, Frank P. K. Hsu6, Richard L. Applegate II7, Ihab R. Dorotta1
1 Department of Anesthesiology, Loma Linda University School of Medicine, CA, USA
2 Department of Anesthesiology, San Juan Regional Medical Center, USA
3 Department of Neurosurgery, The Greater Houston Neurosurgery Center, TX, USA
4 School of Public Health, Loma Linda University, CA, USA
5 Department of Neurosurgery, Cleveland Clinic Foundation, Ohio, USA
6 Department of Neurosurgery, University of California, Irvine, USA
7 Department of Anesthesiology, University of California, Davis, USA


Article Metrics

CrossRef Citations:
1
Total Statistics:

Full-Text HTML Views: 783
Abstract HTML Views: 240
PDF Downloads: 87
ePub Downloads: 51
Total Views/Downloads: 1161
Unique Statistics:

Full-Text HTML Views: 272
Abstract HTML Views: 161
PDF Downloads: 64
ePub Downloads: 41
Total Views/Downloads: 538



© Chang et al.; Licensee Bentham Open

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Department of Anesthesiology, Loma Linda University School of Medicine, 11234 Anderson St, Loma Linda, CA 92354, USA; Tel: 909-558-4000; Ex. 47430; Fax: 909-558-4143; E-mail: rraval@llu.edu


Abstract

Background:

Aneurysmal subarachnoid hemorrhages are frequently complicated by hypertension and neurogenic myocardial stunning. Beta blockers may be used for management of these complications. We sought to investigate sympathetic nervous system modulation by beta blockers and their effect on radiographic vasospasm, delayed cerebral infarction, discharge destination and death.

Methods:

Retrospective chart review of 218 adults admitted to the ICU between 8/2004 and 9/2010 was performed. Groups were identified relevant to beta blockade: 77 were never beta blocked (No/No), 123 received post-admission beta blockers (No/Yes), and 18 were continued on their home beta blockers (Yes/Yes). Records were analyzed for baseline characteristics and the development of vasospasm, delayed cerebral infarction, discharge destination and death, expressed as adjusted odds ratio.

Results:

Of the 218 patients 145 patients developed vasospasm, 47 consequently infarcted, and 53 died or required care in a long-term facility. When compared to No/No patients, No/Yes patients had significantly increased vasospasm (OR 2.11 (1.06-4.16)). However, these patients also had significantly fewer deaths or need for long term care (OR 0.17 (0.05-0.64)), with decreased tendency for infarcts (OR 0.70 (0.32-1.55)). When compared to No/No patients, Yes/Yes patients demonstrated a trend toward increased vasospasm (OR 1.61 (0.50-5.29)) that led to infarction (OR 1.51 (0.44-5.13)), but with decreased mortality or need for long term care in a facility (OR 0.13 (0.01-1.30)).

Conclusion:

Post-admission beta blockade in aneurysmal subarachnoid hemorrhage patients was associated with increased incidence of vasospasm. However, despite the increased occurrence of vasospasm, beta blockers were associated with improved discharge characteristics and fewer deaths.

Keywords: Subarachnoid hemorrhage, Beta blockade, aSAH, CT angiogram, GCS.